International Business Machines Corporation Company Profile (NYSE:IBM)

International Business Machines Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "IBM."

International Business Machines Corporation declared a quarterly dividend on Tuesday, July 25th. Investors of record on Thursday, August 10th will be paid a dividend of $1.50 per share on Saturday, September 9th. This represents a $6.00 dividend on an annualized basis and a yield of 4.11%. The ex-dividend date of this dividend is Tuesday, August 8th. View International Business Machines Corporation's Dividend History.

International Business Machines Corporation (NYSE:IBM) issued its quarterly earnings results on Tuesday, July, 18th. The company reported $2.97 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $2.74 by $0.23. The business had revenue of $19.29 billion for the quarter, compared to analyst estimates of $19.45 billion. International Business Machines Corporation had a return on equity of 71.53% and a net margin of 14.58%. The company's revenue for the quarter was down 4.7% on a year-over-year basis. During the same period last year, the company earned $2.95 EPS. View International Business Machines Corporation's Earnings History.

International Business Machines Corporation is scheduled to release their next quarterly earnings announcement on Monday, October, 16th 2017. View Earnings Estimates for International Business Machines Corporation.

27 equities research analysts have issued 1-year target prices for International Business Machines Corporation's shares. Their forecasts range from $110.00 to $200.00. On average, they expect International Business Machines Corporation's share price to reach $157.63 in the next twelve months. View Analyst Ratings for International Business Machines Corporation.

Here are some recent quotes from research analysts about International Business Machines Corporation stock:

• 1. According to Zacks Investment Research, "IBM’s recently announced second-quarter 2017 results exhibited the company’s growing focus on “Strategic Imperatives” as long-term growth drivers. However, revenue growth remained elusive as these “Strategic Imperatives” failed to offset the weakness in traditional businesses. Moreover, third-quarter revenue guidance reflects negative impact from seasonality, which is anticipated to be partially neutralized by higher contributions from the new Mainframe z14 product and services contracts. Despite sluggish revenue growth projections in the near term, IBM maintained 2017 earnings guidance suggesting improving strength in cloud, mobile, security and social products as well as cost savings. However, intensifying competition in most of the markets remains a major concern." (7/19/2017)
• 2. Cantor Fitzgerald analysts commented, "Foresi’s Take. Strategic Imperatives revenue growth of 7% y/y cc was light and below our expectations. The core business continued to decline, similar to the prior period. Each business segment was down y/y. Margins were just above expectations as the company had sequential gross margin improvement in each business segment. IBM maintained 2017 EPS guidance, with expectations that earnings growth will be weighted to 4Q. Guidance implies around 75bps of annual margin expansion, by our estimates." (7/19/2017)
• 3. Drexel Hamilton analysts commented, "We continue to believe IBM will emerge from this transition a much stronger IT organization. That said, IBM’s stock has been weak around earnings, falling the day after quarterly earnings reports by an average of 3% over the past fourteen quarters (down twelve times). In the meantime, IBM’s 3.9% dividend yield and modest valuation should attract more value investors. IBM reported 2Q:17 sales of $19.29 billion (down 5% YoY; down 3% in constant currency, CC) that beat our revenue estimate of $19.11 billion but missed the Street (consensus was at $19.45 billion) as we highlighted was possible in our earnings preview, while pro forma EPS of $2.97 (up 1%) beat our $2.75 projection and the Street’s estimate of $2.75. A lower tax rate added approximately $0.12 to EPS relative to our projections." (7/18/2017)
• 4. Guggenheim analysts commented, "We believe IBM’s organic revenue growth needs to stabilize or gross margins need to recover, but do not expect either near-term. Our Q2 estimates (unchanged) are for IBM’s revenue to have declined another 3%Y/Y to $19.6B and EPS -7%Y/Y to $2.75, in line with consensus $19.5B/$2.75. We expect focus to be on organic growth, but estimate revenue -4%Y/Y ex M&A, and gross margin down another 240bps Y/Y, only slightly better than Q1’s 300bps Y/Y erosion. We presume IBM will maintain its 2017E EPS outlook for at least $13.80 but continue to see that requiring an extraordinarily big Q4 (without non-operating stretch helpers), with our own estimate still $13.61 even factoring in a Q4 mainframe refresh. We estimate Tech/Cloud Services (-3%Y/Y), GBS/Consulting (-4%Y/Y) and Systems (-16%Y/Y) all soft again in Q2, with Cognitive Solutions growing but just +2%Y/Y even with the help of last year’s M&A and investments in Watson AI." (7/14/2017)
• 5. Wells Fargo & Company analysts commented, "BM's Investor Briefing highlighted the progress the company has made with Watson with one key message being the platform is now reaching scale (expects Watson to touch 1Bn clients by year-end). While our primary concern had been the potential lack of leverage due to continual reinvestment back into building Watson for other industry verticals, IBM highlighted standing up new industries/applications takes less time and investment as the platform improves and matures and mgmt noted it does not intend on participating in all industries. Presentations from customers in various industries highlight the importance of IBM's industry expertise and reinforced our view of IBM's vertically focused analytics strategy in markets where it has deep domain expertise through its services business. However, despite comments around Watson scaling, the benefits are not yet overtly transparent to the overall financials. We believe IBM has the right strategy and is gaining traction though not necessarily reflected in results due to pressures in the legacy businesses, reinvestments, FX, and business models (SaaS, pay per insight, etc). We expect these pressures to continue in 2017 though are hopeful 2018 could show improvement. We raise our valuation range to $175-$185 based on 13x our 2017 EPS driven by market multiple expansion but maintain our Market Perform rating." (3/8/2017)

Some companies that are related to International Business Machines Corporation include Accenture PLC (ACN), Automatic Data Processing (ADP), Vmware (VMW), Cognizant Technology Solutions Corporation (CTSH), NetEase (NTES), Infosys Limited (INFY), Wipro Limited (WIT), CGI Group (GIB), Total System Services (TSS), Palo Alto Networks (PANW), Gartner (IT), VeriSign (VRSN), CDW Corporation (CDW), Amdocs Limited (DOX), Akamai Technologies (AKAM), Jack Henry & Associates (JKHY), F5 Networks (FFIV) and Fortinet (FTNT).

International Business Machines Corporation's management team includes the folowing people:

• Virginia M. Rometty, Chairman of the Board, President, Chief Executive Officer
• Martin J. Schroeter, Chief Financial Officer, Senior Vice President
• Michelle H. Browdy, Senior Vice President - Legal and Regulatory Affairs and General Counsel
• Diane J. Gherson, Senior Vice President - Human Resources
• Erich Clementi, Senior Vice President - IBM Global Markets
• James J. Kavanaugh, Senior Vice President - Transformation and Operations
• John E. Kelly III, Senior Vice President - IBM Cognitive Solutions and IBM Research
• Kenneth M. Keverian, Senior Vice President - Corporate Strategy
• Robert F. Del Bene, Vice President, Controller
• Kenneth I. Chenault, Independent Director

International Business Machines Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.68%), Berkshire Hathaway Inc. (5.80%), BlackRock Inc. (5.68%), State Street Corp (5.40%), State Farm Mutual Automobile Insurance Co. (1.79%) and Northern Trust Corp (1.14%). Company insiders that own International Business Machines Corporation stock include David N Farr, Diane J Gherson, Erich Clementi, James J Kavanaugh, James W Owens, Joan E Spero, John E Kelly III, Jon C Iwata, Kenneth I Chenault, Kralingen Bridget A Van, Leo Allen Bruno V Di, Michael D Rhodin, Michael L Eskew, Robert J Leblanc, Robert J Picciano, Steven A Mills, Thomas W Rosamilia and Virginia M Rometty. View Institutional Ownership Trends for International Business Machines Corporation.

International Business Machines Corporation's stock was sold by a variety of institutional investors in the last quarter, including Berkshire Hathaway Inc., Capital Research Global Investors, Capital International Investors, State Street Corp, Alecta Pensionsforsakring Omsesidigt, Bank of New York Mellon Corp, Bank of Nova Scotia and Focused Investors LLC. Company insiders that have sold International Business Machines Corporation stock in the last year include Diane J Gherson, James J Kavanaugh, John E Kelly III, Jon C Iwata, Kralingen Bridget A Van and Michael D Rhodin. View Insider Buying and Selling for International Business Machines Corporation.

International Business Machines Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Nordea Investment Management AB, Janus Henderson Group PLC, BlackRock Inc., Renaissance Technologies LLC, Arrowstreet Capital Limited Partnership, Parametric Portfolio Associates LLC and Toronto Dominion Bank. Company insiders that have bought International Business Machines Corporation stock in the last two years include David N Farr and James W Owens. View Insider Buying and Selling for International Business Machines Corporation.

Shares of International Business Machines Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of International Business Machines Corporation stock can currently be purchased for approximately $145.87.